Eskazan, A. E. 2018. Further augmentation of molecular responses with dasatinib therapy in chronic myeloid leukemia patients who gained major molecular response under imatinib. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.23, no.2 , 400-401.

Eskazan, A. E., (2018). Further augmentation of molecular responses with dasatinib therapy in chronic myeloid leukemia patients who gained major molecular response under imatinib. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.23, no.2, 400-401.

Eskazan, Ahmet. "Further augmentation of molecular responses with dasatinib therapy in chronic myeloid leukemia patients who gained major molecular response under imatinib," INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.23, no.2, 400-401, 2018

Eskazan, Ahmet E. . "Further augmentation of molecular responses with dasatinib therapy in chronic myeloid leukemia patients who gained major molecular response under imatinib." INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.23, no.2, pp.400-401, 2018

Eskazan, A. E. (2018) . "Further augmentation of molecular responses with dasatinib therapy in chronic myeloid leukemia patients who gained major molecular response under imatinib." INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.23, no.2, pp.400-401.

@article{article, author={Ahmet Emre EŞKAZAN}, title={Further augmentation of molecular responses with dasatinib therapy in chronic myeloid leukemia patients who gained major molecular response under imatinib}, journal={INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY}, year=2018, pages={400-401} }